You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
18 July 2022
XPhyto Therapeutics Corp.: XPhyto Pursues Potential Application of its Oral Dissolvable Biosensor Inflammation Test for Buprenorphine-related Dental Disease
15 December 2021
XPhyto Therapeutics Corp.: XPhyto Epilepsy Clinical Trial Planned in 2022 with Its Proprietary Fast-Dissolving CBD Oral Strips
6 December 2021
XPhyto Therapeutics Corp.: XPhyto Completes Strategic Acquisition of 3a-diagnostics GmbH
18 March 2021
XPhyto Therapeutics Corp.: XPhyto announces European Approval for 25 Minute COVID-19 PCR Test
4 March 2021
XPhyto Therapeutics Corp.: XPhyto Completes Corporate Rebranding and Launches New Website
24 February 2021
XPhyto Therapeutics Corp.: XPhyto Places First Order for 25-Minute Covid-19 RT-PCR Tests